Awareness: The First Step to Action
Carotid Intima-Media Thickness in Familial Combined Hyperlipidemia and LDL Size
Measuring Quality of Life After Stroke Using the SF-36
Race and Sex Differences in the Effects of Dietary Potassium Intake on the Risk of Stroke
Race and Sex Differences in the Effects of Dietary Potassium Intake on the Risk of Stroke
Prevalence and Risk Factors of Silent Brain Infarcts in the Population
Prevalence and Risk Factors of Silent Brain Infarcts in the Population
Cerebral Atherosclerosis Causes Neurogenic Hypertension
Cerebral Atherosclerosis Causes Neurogenic Hypertension
Multiple Panel of Biomarkers for TIA/Stroke Evaluation
Dietary Intake of Folate and Risk of Stroke in US Men and Women
Genetic and Environmental Risk Factors for Intracerebral Hemorrhage
Sex Differences in US Mortality Rates for Stroke and Stroke Subtypes by Race/Ethnicity and Age, 1995–1998
Risk of Arterial Thrombosis in Relation to Oral Contraceptives (RATIO) Study
Trends in Stroke Prevalence Between 1973 and 1991 in the US Population 25 to 74 Years of Age
Bone Formation in Carotid Plaques
Large and Deep Brain Arteriovenous Malformations Are Associated With Risk of Future Hemorrhage
Global Cerebral Edema After Subarachnoid Hemorrhage
Clinical Course of Cranial Dural Arteriovenous Fistulas With Long-Term Persistent Cortical Venous Reflux
Platelet P-Selectin Levels in Relation to Plasma Soluble P-Selectin and β-Thromboglobulin Levels in Atrial Fibrillation
Regional Cerebral Blood Flow and Magnetic Resonance Spectroscopic Imaging Findings in Diaschisis From Stroke
Chlamydia pneumoniae Serology Is Associated With Thrombosis-Related but Not With Plaque-Related Microembolization During Carotid Endarterectomy
Association Between Carotid Intima-Media Thickness and Low-Density Lipoprotein Size and Susceptibility of Low-Density Lipoprotein to Oxidation in Asymptomatic Members of Familial Combined Hyperlipidemia Families
Modified National Institutes of Health Stroke Scale for Use in Stroke Clinical Trials
Acute Ischemic Stroke Patterns in Infective and Nonbacterial Thrombotic Endocarditis
Hemodynamic Studies in Early Ischemic Stroke
Magnetic Resonance Angiography in Childhood Arterial Brain Infarcts
Brain Representation of Hemifield Stimulation in Poststroke Visual Field Defects
Changes in Blood Flow and Oxygen Metabolism During Visual Stimulation in Carotid Artery Disease
Early Dramatic Recovery During Intravenous Tissue Plasminogen Activator Infusion
Carotid Artery Stenting Protected With an Emboli Containment System
Blood Pressure and Clinical Outcomes in the International Stroke Trial
Subarachnoid Hemorrhage
Poststroke Fatigue
Acute Stroke Care in Illinois
Guideline Compliance Improves Stroke Outcome
Quality of Life Measurement After Stroke
Influence of Apolipoprotein E, Smoking, and Alcohol Intake on Carotid Atherosclerosis
Bone Marrow as a Source of Endothelial Cells and NeuN-Expressing Cells After Stroke
Persistent Defect in Transmitter Release and Synapsin Phosphorylation in Cerebral Cortex After Transient Moderate Ischemic Injury
Endovascular Microcoil Gene Delivery Using Immobilized Anti-adenovirus Antibody for Vector Tethering
Malignant Infarction in Cats After Prolonged Middle Cerebral Artery Occlusion
Prediction of Hemorrhagic Transformation After Thrombolytic Therapy of Clot Embolism
Can Transcranial Ultrasonication Increase Recanalization Flow With Tissue Plasminogen Activator?
MRI Evaluation and Functional Assessment of Brain Injury After Hypoxic Ischemia in Neonatal Mice
Neuroprotective Effects of the Spin Trap Agent Disodium-[(tert-butylimino)methyl]benzene-1,3-disulfonate N-Oxide (Generic NXY-059) in a Rabbit Small Clot Embolic Stroke Model
Lack of Evidence for Pulmonary Venous Thrombosis in Cryptogenic Stroke
Carotid Intima-Media Thickness Is Associated With Allelic Variants of Stromelysin-1, Interleukin-6, and Hepatic Lipase Genes
Acute Basilar Artery Occlusion Treated With Combined Intravenous Abciximab and Intra-arterial Tissue Plasminogen Activator
Cerebral Infarction Due to Carotid Occlusion Caused by Cervical Vagal Neurilemmoma
Falls, Fractures, and Osteoporosis After Stroke
Thrombolytic Therapy Within 3 to 6 Hours After Onset of Ischemic Stroke